Zenith Drugs Limited (NSE:ZENITHDRUG)

Zenith Drugs Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	88.03	2.79	30.01	18.48	4.36
Short-Term Investments	-	-	-	-	13.44
Cash & Short-Term Investments	88.03	2.79	30.01	18.48	17.8
Cash Growth	3053.96%	-90.70%	62.37%	3.83%	19.10%
Accounts Receivable	673.95	493.11	320.68	233.82	254.34
Other Receivables	-	-	0.68	-	28.89
Receivables	676.32	496.32	321.36	233.82	283.23
Inventory	257.58	236.73	121.31	68.32	43.63
Prepaid Expenses	-	-	3.37	0.21	0.57
Other Current Assets	111.34	103.38	59.25	37.67	1.94
Total Current Assets	1,133	839.22	535.3	358.49	347.17
Property, Plant & Equipment	152.42	116.98	131.23	92.06	89.91
Other Intangible Assets	0.07	0.1	0.12	0.13	0.16
Long-Term Deferred Tax Assets	0.66	-	-	-	-
Other Long-Term Assets	-0	0	19.2	14.79	-
Total Assets	1,350	979.25	685.85	465.47	437.24
Accounts Payable	426.31	508.74	346.81	202.64	197.26
Accrued Expenses	5.22	11.28	10.7	9.34	30.84
Short-Term Debt	140.06	157.89	40.57	52.03	24.51
Current Portion of Long-Term Debt	20.74	19.6	51.81	30.04	37.98
Current Income Taxes Payable	38.91	17.58	13.34	3.56	15.15
Other Current Liabilities	10.22	1.45	2.55	2.14	6.47
Total Current Liabilities	641.47	716.54	465.78	299.75	312.21
Long-Term Debt	85.59	83.63	95.71	72.75	58.24
Long-Term Deferred Tax Liabilities	-	1.72	2.63	3.08	1.08
Other Long-Term Liabilities	-0	-	-	0	0
Total Liabilities	727.05	801.89	564.79	375.94	371.52
Common Stock	171.49	4	4	4	4
Additional Paid-In Capital	306.58	2	2	2	2
Retained Earnings	144.57	171.22	114.91	83.53	59.71
Total Common Equity	622.64	177.22	120.91	89.53	65.71
Minority Interest	0.68	0.15	0.15	-	-
Shareholders' Equity	623.33	177.36	121.06	89.53	65.71
Total Liabilities & Equity	1,350	979.25	685.85	465.47	437.24
Total Debt	246.39	261.12	188.09	154.81	120.73
Net Cash (Debt)	-158.36	-258.33	-158.08	-136.33	-102.93
Net Cash Per Share	-9.23	-21.53	-13.17	-11.36	-8.58
Filing Date Shares Outstanding	17.15	12	12	12	12
Total Common Shares Outstanding	17.15	12	12	12	12
Working Capital	491.8	122.68	69.52	58.74	34.97
Book Value Per Share	36.31	14.77	10.08	7.46	5.48
Tangible Book Value	622.57	177.12	120.79	89.39	65.56
Tangible Book Value Per Share	36.30	14.76	10.07	7.45	5.46
Land	-	-	27.47	9.49	9.49
Buildings	-	-	52.8	52.18	32.51
Machinery	-	-	87.45	80.25	59.54
Construction In Progress	-	-	26.62	-	26.1

Updated May 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.